DOI: 10.5281/zenodo.7066829
title: Length of hospital stay, Clinical and Therapeutic characteristics of patients with COVID-19

description: Background: The Covid-19 (SARS-CoV-2) pandemic marked unprecedented on healthcare sector globally with increase demand of hospital beds, intensive care facilities, lifesaving supplies and equipments. This retrospective study of two healthcare centers focuses on length of hospital stay, clinical and therapeutic characteristics of patients with COVID-19. These parameters help to identify the available resources and to determine the optimum requirements of healthcare units in pandemics. Materials and Methods: The retrospective data was collected between 12<sup>th</sup> of March and 30<sup>th</sup> of Jun 2020 of polymerase chain reaction (PCR) confirming SARS-COV-2 patients and categorized into mild, moderate, and severe diseased groups based on symptoms and its severity of COVID 19. Results: A total of 843 SARS-COV-2 positive patients were identified for this study, 132 were mild symptomatic cases<em>, </em>168<em>, </em>moderate symptomatic, and 17 were severe symptomatic with mean age of 34.95 ± 15.9 years. The mean length of hospital stay was 16.38, 13.18, 13.72, 9.30, 6.96, 10.86, 5.77 and 7.37 from 1 to 8 treatments consecutively, with 156.327 Chi-square, and 0.000* p-value. Kruskal-Wallis test shows there were significant differences seen between the length of hospital stay among different treatment groups with chi-square (7) = 156.327, with p-value of 0.000(p-value&lt;0.005). Treatment group 1 who were on antiviral had the highest mean no. of hospital stay while treatment group 7 patients who were on no treatments had the lowest stay with mean duration of 5.7days. Conclusion: Length of hospital stay, clinical and therapeutic characteristics of patients with COVID-19 are crucial indicators of pandemic management. The lower length of hospital stay is a positive outcome of better Covid-19 management. Background: The Covid-19 (SARS-CoV-2) pandemic marked unprecedented on healthcare sector globally with increase demand of hospital beds, intensive care facilities, lifesaving supplies and equipments. This retrospective study of two healthcare centers focuses on length of hospital stay, clinical and therapeutic characteristics of patients with COVID-19. These parameters help to identify the available resources and to determine the optimum requirements of healthcare units in pandemics. Materials and Methods: The retrospective data was collected between 12<sup>th</sup> of March and 30<sup>th</sup> of Jun 2020 of polymerase chain reaction (PCR) confirming SARS-COV-2 patients and categorized into mild, moderate, and severe diseased groups based on symptoms and its severity of COVID 19. Results: A total of 843 SARS-COV-2 positive patients were identified for this study, 132 were mild symptomatic cases<em>, </em>168<em>, </em>moderate symptomatic, and 17 were severe symptomatic with mean age of 34.95 ± 15.9 years. The mean length of hospital stay was 16.38, 13.18, 13.72, 9.30, 6.96, 10.86, 5.77 and 7.37 from 1 to 8 treatments consecutively, with 156.327 Chi-square, and 0.000* p-value. Kruskal-Wallis test shows there were significant differences seen between the length of hospital stay among different treatment groups with chi-square (7) = 156.327, with p-value of 0.000(p-value&lt;0.005). Treatment group 1 who were on antiviral had the highest mean no. of hospital stay while treatment group 7 patients who were on no treatments had the lowest stay with mean duration of 5.7days. Conclusion: Length of hospital stay, clinical and therapeutic characteristics of patients with COVID-19 are crucial indicators of pandemic management. The lower length of hospital stay is a positive outcome of better Covid-19 management.